Your Call Is Confidential
The Department of Justice recently announced the settlement of a qui tam lawsuit against Toyobo, the sole manufacturer of Zylon fiber used in bulletproof vests, in relation to their violation of the False Claims Act (FCA). According to the allegations of the case, between 2001 and 2005, Toyobo actively marketed and sold defective Zylon fiber […]
The Department of Justice (“DOJ”) recently settled a False Claims Act (“FCA”) lawsuit with Brattleboro Memorial Hospital (“BMH”). Pursuant to the settlement, BMH agreed to pay $1.65 Million to the United States and the State of Vermont to resolve allegations that the company violated the False Claims Act through submitting false or fraudulent claims to […]
On Tuesday, January 30, 2018, United States Attorney for the Middle District of Florida Maria Chapa Lopez announced the settlement of a false claims act case against AmeriCare Ambulance Service, Inc. and its sister company, AmeriCare ALS, Inc. (collectively, AmeriCare). AmeriCare, the largest ambulance service provider in Tampa, Florida., will pay $5.5 million and enter […]
DaVita Rx LLC, a nationwide pharmacy specialized in serving patients with severe kidney disease has agreed to resolve allegations that the company defrauded the Government through improper overbilling of the Medicare and Medicaid healthcare programs for medications that were never shipped, billing for medications that did not comply with documentation requirements, and failing to reverse […]
On September 14, 2017, Pacific Architects & Engineers Incorporated (PAE) settled a whistleblower lawsuit alleging the company did not follow proper vetting procedures for its personnel that performed and billed work to the U.S. State Department. The $5 million settlement resolves allegations without any determination of liability of contract violations. PAE is a company originally […]
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. (collectively, “Mylan”) have settled allegations that they violated the False Claims Act when they misclassified EpiPen as a generic drug as part of a scheme to avoid paying rebates owed to the federal government. Mylan has agreed to […]
On August 21, 2017, Acting United States Attorney Gregory G. Brooker of the United States Attorney’s Office for the District of Minnesota announced that the U.S. government reached a settlement of $12 million with Sightpath Medical over its alleged use of kickbacks to promote its products, in violation of federal law. Whistleblower Kipp Fesenmaier, former […]
On August 3, 2017, the United States Attorney for the Middle District of Georgia and the Georgia Attorney General announced Navicent Health’s $2.5 million settlement to resolve allegations of violating the False Claims Act and billing Medicare and Medicaid for ambulance trips that were overpriced or not medically necessary. Navicent Health, Inc. owns and operates […]
Celgene Corp., a New Jersey pharmaceutical manufacturer, has agreed to pay $280 million to settle a False Claims Act lawsuit related to allegations that it promoted cancer drugs for uses that had not been approved by the Food and Drug Administration (“FDA”). Under the terms of the agreement, which does not include any admission of […]
Nursing home operator Genesis HealthCare (“Genesis”) has agreed to resolve allegations that the company’s subsidiaries previously submitted false claims to the government for payment for unnecessary hospice services that were provided to Medicaid and Medicare beneficiaries. The recent settlement is the result of allegations that stemmed from five separate qui tam, or whistleblower, lawsuits that […]
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.
1828 L Street, NW - Suite 1000 • Washington, D.C. 20036
Tel: (202) 973-0900 • Fax: (202) 973-0950
483 Ninth Street, Suite 200 ∙ Oakland, CA 94607
Tel: (510) 254-6808